Cytomegalovirus immunoglobulin (Cytotect CP Biotest)

Status:
Red
Decision Date:
March 2020
 

Comments

RED: Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy.

 NHS England drug.  To be used in line with NHSE commissioning intentions.

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app